血管摄影导管市场规模、份额及成长分析（按产品类型、应用、最终用户和地区划分）－产业预测（2026-2033 年）

预计到 2024 年，血管摄影导管市场规模将达到 16.2 亿美元，到 2025 年将达到 17.5 亿美元，到 2033 年将达到 31.8 亿美元，在预测期（2026-2033 年）内，复合年增长率为 7.8%。

血管摄影导管市场正经历蓬勃发展，这主要得益于医疗技术的进步和对高精度诊断工具日益增长的需求。这些导管在现代心血管护理中发挥关键作用，能够对复杂的血管问题进行即时成像和治疗性介入。人口老化以及人们对早期诊断和微创治疗益处的认识不断提高，显着推动了市场需求。材料创新和导航技术的改进使得手术更加安全、精准，有助于改善病患的治疗效果。然而，监管障碍和这些先进设备的高成本等挑战可能会阻碍其成长潜力。总体而言，该市场体现了透过持续创新和适应患者需求来改善心血管护理的决心。

血管摄影导管市场驱动因素

冠状动脉疾病和血管疾病等心血管疾病的日益普及是血管造影导管市场的主要驱动力。人口老化以及生活方式因素对心血管健康的影响日益加剧，推动了对高效诊断设备和微创治疗方案（例如血管造影导管）的需求。这些设备在诊断和治疗过程中都至关重要，从而带动了市场需求的成长。此外，科技的进步和对以病人为中心的照护的日益重视，也持续提升了这些导管的吸引力，促进了其在医疗机构中的广泛应用。

限制血管摄影导管市场的因素

血管摄影导管市场的发展可能面临许多挑战，包括购买和维护必要设备以及手术费用带来的沉重经济负担。除了导管系统的购买成本外，由于需要培训医护人员正确使用，总拥有成本也很高。这些高成本可能构成重大的准入障碍，尤其是在经济资源有限的地区，并可能阻碍这些医疗技术的广泛应用，进而影响到本可从中受益的患者。

血管摄影导管市场趋势

血管摄影导管市场正经历一个显着的趋势：对微创手术的需求日益增长。随着患者和医疗机构逐渐认识到微创手术的诸多优势，例如更快的恢復时间、更短的住院时间和更低的併发症风险，对血管造影导管的需求也不断增长。这些专用器械能够在复杂的血管系统中实现精准导航，是进行创新性介入手术的关键。这一趋势的驱动力源于导管技术的进步，这些进步提高了手术的精准度和效率，以及熟练这些先进手术技术的医务人员技能的不断提升。这种协同作用正在推动市场发展。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究
• 监管环境
• 专利分析

全球血管摄影导管市场规模（依产品类型及复合年增长率划分）（2026-2033 年）

• 常规导管
• 折迭球囊导管
• DEB导管
• 切割球囊导管

全球血管摄影导管市场规模（按应用及复合年增长率划分）（2026-2033 年）

• 冠状动脉
• 血管内治疗
• 神经病学
• 肿瘤学
• 其他用途

全球血管摄影导管市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

• 医院
• 门诊手术中心
• 诊断中心

全球血管摄影导管市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• AngioDynamics Inc.（USA）
• Boston Scientific Corporation（USA）
• Cook Group Inc.（USA）
• Cardinal Health Inc.（USA）
• Medtronic Plc（Ireland）
• Merit Medical Systems（USA）
• Terumo Corporation（Japan）
• B. Braun Melsungen AG（Germany）
• Becton, Dickinson and Company（USA）
• Koninklijke Philips NV（Netherlands）
• Alvimedica（Turkey）
• Haemonetics Corporation（USA）
• InSitu Technologies Inc.（USA）
• McKesson Corporation（USA）
• Teleflex Incorporated（USA）
• Abbott Laboratories（USA）
• Asahi Intecc Co., Ltd.（Japan）
• Nipro Corporation（Japan）
• Penumbra, Inc.（USA）
• Stryker Corporation（USA）

结论与建议

Angiographic Catheters Market size was valued at USD 1.62 Billion in 2024 and is poised to grow from USD 1.75 Billion in 2025 to USD 3.18 Billion by 2033, growing at a CAGR of 7.8% during the forecast period (2026-2033).

The Angiographic Catheters Market showcases dynamic growth, influenced by advancements in medical technology and the increasing demand for high-precision diagnostic tools. These catheters play a vital role in contemporary cardiovascular treatments, facilitating real-time imaging and therapeutic interventions for complex vascular issues. The aging population, coupled with rising awareness about the benefits of early diagnosis and minimally invasive approaches, significantly boosts market demand. Innovations in materials and enhanced navigation features contribute to safer and more accurate procedures, promoting better patient outcomes. Nonetheless, challenges such as regulatory hurdles and the high costs of these advanced devices may hinder growth potential. Overall, this market reflects a commitment to elevating cardiovascular care through continuous innovation and adaptation to patient needs.

Top-down and bottom-up approaches were used to estimate and validate the size of the Angiographic Catheters market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Angiographic Catheters Market Segments Analysis

Global Angiographic Catheters Market is segmented by Product Type, Application, End-User and region. Based on Product Type, the market is segmented into Conventional Catheters, Scoring Balloon Catheters, DEB Catheters and Cutting Balloon Catheters. Based on Application, the market is segmented into Coronary, Endovascular, Neurology, Oncology and Other Applications. Based on End-User, the market is segmented into Hospitals, Ambulatory Surgical Centers and Diagnostic Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Angiographic Catheters Market

The rising prevalence of cardiovascular conditions, such as coronary artery diseases and vascular disorders, significantly propels the angiographic catheters market. As populations age and lifestyle choices increasingly impact cardiovascular health, there is a heightened need for effective diagnostic instruments and minimally invasive treatment solutions, such as angiographic catheters. These devices are crucial in facilitating both diagnosis and therapeutic procedures, leading to an upward trend in market demand. Furthermore, advancements in technology and an emphasis on patient-centric care continue to enhance the appeal of these catheters, contributing to their expanded adoption across healthcare settings.

Restraints in the Angiographic Catheters Market

The growth of the angiographic catheters market may face challenges due to the considerable financial burden linked with acquiring and maintaining the necessary equipment, as well as the procedural expenditures. The expense involved in purchasing catheter systems, coupled with the need for training healthcare professionals for proper usage, contributes to a high total cost of ownership. These elevated costs can pose significant barriers to access, particularly in areas with limited financial resources, thereby impeding widespread adoption of these medical technologies and affecting their availability to patients who may benefit from their use.

Market Trends of the Angiographic Catheters Market

The Angiographic Catheters market is experiencing a notable trend characterized by the growing preference for minimally invasive procedures. As both patients and healthcare providers recognize the numerous advantages these procedures offer-such as quicker recovery times, shorter hospital stays, and lower risk of complications-demand for angiographic catheters is rising. These specialized devices facilitate accurate navigation within complex vascular systems, vital for executing these innovative interventions. Contributing to this trend are enhancements in catheter technology that bolster precision and efficiency, along with the increasing expertise of medical professionals who are adept at executing these advanced procedures. This convergence is propelling the market forward.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis

Global Angiographic Catheters Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Conventional Catheters
• Scoring Balloon Catheters
• DEB Catheters
• Cutting Balloon Catheters

Global Angiographic Catheters Market Size by Application & CAGR (2026-2033)

• Market Overview
• Coronary
• Endovascular
• Neurology
• Oncology
• Other Applications

Global Angiographic Catheters Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Diagnostic Centers

Global Angiographic Catheters Market Size & CAGR (2026-2033)

• North America (Product Type, Application, End-User)
  • US
  • Canada
• Europe (Product Type, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• AngioDynamics Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Group Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic Plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alvimedica (Turkey)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Haemonetics Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• InSitu Technologies Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• McKesson Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Intecc Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Penumbra, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations